Busch, CatharinaFraser-Bell, SamanthaZur, DinahRodríguez-Valdés, Patricio J.Cebeci, ZaferLupidi, MarcoFung, Adrian T.Gabrielle, Pierre-HenryGiancipoli, ErmeteChaikitmongkol, VorapornOkada, MaliLaíns, InêsSantos, Ana Ritakunavisarut, ParadeeSala-Puigdollers, AnnaChhablani, JayOzimek, MalgorzataHilely, AssafUnterlauft, Jan DariusLoewenstein, AnatIglicki, MatiasRehak, Matus2021-02-082021-02-082019-03-22Busch, C., Fraser-Bell, S., Zur, D., Rodríguez-Valdés, P. J., Cebeci, Z., Lupidi, M., . . . For the International Retina, G. (2019). Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study. Acta Diabetologica, 56(7), 777-784. doi:10.1007/s00592-019-01310-zhttp://hdl.handle.net/10400.22/16907In a real-world setting, the majority of DME patients with very good VA maintained vision at 12 months, regard- less of whether the DME was treated or not. This study supports close observation of eyes with DME and very good VA with consideration of treatment when a one line drop in vision is observed.engDiabetic macular edemaGood visual acuityObservationAnti-VEGF therapyIntravitreal therapyMacular laserjournal article10.1007/s00592-019-01310-z